From Pandemic to Endemic: How Vaccines are the Nexus for Science, Policy & Public Health in Stopping Pandemics
Check Back
Oct 28, 2021
Check Back
12:00 pm
1:00 pm

As we near the two-year mark of the COVID-19 pandemic, many are asking “what’s next.” While more than half of Americans are fully vaccinated, we are still seeing COVID cases rise. Vaccine hesitancy persists and deaths among the unvaccinated are prevalent and critical. We are continuing to learn best practices to navigate this pandemic, but what steps can we really take to turn this into an endemic? Please join our panel of experts to learn how science, policy, and public health working together is key and how we can use these lessons to prepare for future pandemics.

Experts Will Explain:

  • What is the history of vaccines and why are they so important to society?
  • Why is surveillance critical to proper vaccine development?
  • Why is there vaccine hesitancy and how do we overcome this?
  • What is the role of public health and policy in combatting current and future pandemics?
  • How can we move this pandemic to an endemic and use innovation for pandemic preparedness?


  • Dr. Michelle Williams – Dean of the Faculty for Harvard T.H. Chan School of Public Health, and Angelopoulos Professor in Public Health and International Development, a joint faculty appointment at the Harvard Chan School and Harvard Kennedy School
  • Dr. Mark Poznansky – Director and Research Scholar for the Vaccine and Immunotherapy Center at Massachusetts General Hospital, Attending Physician Infectious Diseases Medicine, Massachusetts General Hospital, and Professor Harvard Medical School
  • Dr. Michael Callahan – President of United Therapeutics, Researcher for the Division of Infectious Disease at Massachusetts General Hospital, Former COVID Advisor for ASPR at HHS, Former Director for DARPA BioDefense Medical Countermeasures, Former Special Advisor for OSTP/NSC under Presidents Obama and Bush